Biomerica Statistics
Share Statistics
Biomerica has 16.82M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 16.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 14.84M |
| Failed to Deliver (FTD) Shares | 5.09K |
| FTD / Avg. Volume | 0.56% |
Short Selling Information
The latest short interest is 782.76K, so 4.65% of the outstanding shares have been sold short.
| Short Interest | 782.76K |
| Short % of Shares Out | 4.65% |
| Short % of Float | 5.28% |
| Short Ratio (days to cover) | 0.37 |
Valuation Ratios
The PE ratio is -1.63 and the forward PE ratio is 0.95.
| PE Ratio | -1.63 |
| Forward PE | 0.95 |
| PS Ratio | 1.8 |
| Forward PS | null |
| PB Ratio | 1.48 |
| P/FCF Ratio | -1.78 |
| PEG Ratio | n/a |
Enterprise Valuation
Biomerica Inc. has an Enterprise Value (EV) of 10.75M.
| EV / Earnings | -1.8 |
| EV / Sales | 1.99 |
| EV / EBITDA | -1.79 |
| EV / EBIT | -1.69 |
| EV / FCF | -1.96 |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.
| Current Ratio | 3.51 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.91% and return on capital (ROIC) is -86.93%.
| Return on Equity (ROE) | -0.91% |
| Return on Assets (ROA) | -0.65% |
| Return on Capital (ROIC) | -86.93% |
| Revenue Per Employee | 84.61K |
| Profits Per Employee | -93.41K |
| Employee Count | 64 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.02 |
Taxes
| Income Tax | 42.00K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -67.62% in the last 52 weeks. The beta is -1.14, so Biomerica 's price volatility has been lower than the market average.
| Beta | -1.14 |
| 52-Week Price Change | -67.62% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.46 |
| Relative Strength Index (RSI) | 55.98 |
| Average Volume (20 Days) | 917.11K |
Income Statement
In the last 12 months, Biomerica had revenue of 5.42M and earned -5.98M in profits. Earnings per share was -0.36.
| Revenue | 5.42M |
| Gross Profit | 611.00K |
| Operating Income | -6.37M |
| Net Income | -5.98M |
| EBITDA | -5.99M |
| EBIT | -6.37M |
| Earnings Per Share (EPS) | -0.36 |
Balance Sheet
The company has 4.17M in cash and 785.00K in debt, giving a net cash position of 3.38M.
| Cash & Cash Equivalents | 4.17M |
| Total Debt | 785.00K |
| Net Cash | 3.38M |
| Retained Earnings | -48.20M |
| Total Assets | 7.87M |
| Working Capital | 4.29M |
Cash Flow
In the last 12 months, operating cash flow was -5.36M and capital expenditures -115.00K, giving a free cash flow of -5.48M.
| Operating Cash Flow | -5.36M |
| Capital Expenditures | -115.00K |
| Free Cash Flow | -5.48M |
| FCF Per Share | -0.33 |
Margins
Gross margin is 1.13K%, with operating and profit margins of -11.76K% and -11.04K%.
| Gross Margin | 1.13K% |
| Operating Margin | -11.76K% |
| Pretax Margin | -10.96K% |
| Profit Margin | -11.04K% |
| EBITDA Margin | -110.67% |
| EBIT Margin | -117.58% |
| FCF Margin | -101.13% |
Dividends & Yields
BMRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -105.88% |
| FCF Yield | -95.72% |
Analyst Forecast
Currently there are no analyst rating for BMRA.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 14, 1994. It was a backward split with a ratio of 1:2.
| Last Split Date | Nov 14, 1994 |
| Split Type | backward |
| Split Ratio | 1:2 |
Scores
| Altman Z-Score | -9.02 |
| Piotroski F-Score | 2 |